Article Versions Notes

Bumes E, Fellner C, Fellner FA, Fleischanderl K, Häckl M, Lenz S, Linker R, Mirus T, Oefner PJ, Paar C, et al. Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo ¹H-Magnetic Resonance Spectroscopy and Machine Learning. Cancers. 2022; 14(11):2762. https://doi.org/10.3390/cancers14112762

Bumes, Elisabeth, Claudia Fellner, Franz A. Fellner, Karin Fleischanderl, Martina Häckl, Stefan Lenz, Ralf Linker, Tim Mirus, Peter J. Oefner, Christian Paar, and et al. 2022. "Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo ¹H-Magnetic Resonance Spectroscopy and Machine Learning" Cancers 14, no. 11: 2762. https://doi.org/10.3390/cancers14112762

Bumes, E., Fellner, C., Fellner, F. A., Fleischanderl, K., Häckl, M., Lenz, S., Linker, R., Mirus, T., Oefner, P. J., Paar, C., Proescholdt, M. A., Riemenschneider, M. J., Rosengarth, K., Weis, S., Wendl, C., Wimmer, S., Hau, P., Gronwald, W., & Hutterer, M. (2022). Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo ¹H-Magnetic Resonance Spectroscopy and Machine Learning. Cancers, 14(11), 2762. https://doi.org/10.3390/cancers14112762